JOHNSON & JOHNSON |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 146.4 USD | -1.29% |
|
0.00% | -6.76% |
| 28/06 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
| 28/06 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
9675d5.hYZ4N6gzfclXF5SPm-djW5fYO0a7tNRc1V3oXTxTY9g.9sM8TplFRPoSb-b3-I1UK8CfcSnewrctojKpO1UMAJbD9BQC8UI75BJB3Q~3de1418f9772f1fdeb741abde50d9021
